Approved Uses for Risperdal in Autism
Risperdal (risperidone) is FDA-approved for irritability associated with autistic disorder in children and adolescents aged 5-16 years, including aggression, deliberate self-injury, and temper tantrums. It is not approved for autism spectrum disorder broadly or in adults.[1]
Maximum Recommended Dose
The maximum recommended dose is 3 mg per day for patients weighing 20 kg or more, and 0.6 mg per day for those under 20 kg (44 lbs). Dosing starts low and titrates up based on response and tolerability, typically reaching maximum within 6-8 weeks.[1][2]
| Weight | Starting Dose | Target Dose Range | Maximum Dose |
|--------|---------------|-------------------|--------------|
| <20 kg | 0.25 mg/day | 0.25-0.5 mg/day | 0.6 mg/day |
| ≥20 kg | 0.5 mg/day | 1-2.5 mg/day | 3 mg/day |
How Dosing Works in Practice
Clinicians individualize doses starting at 0.25-0.5 mg daily, increasing by 0.25-0.5 mg every 1-2 weeks. Most patients stabilize at 1-2.5 mg/day. Higher doses do not improve efficacy and raise risks.[1][3]
What Happens Beyond Maximum Dose
Doses above 3 mg/day (or 0.6 mg for lighter children) show no added benefit in trials and increase adverse effects like weight gain, sedation, and extrapyramidal symptoms. Off-label use at higher doses occurs rarely but lacks supporting data.[2][4]
Common Side Effects at Higher Doses
Weight gain (up to 18% body weight increase), somnolence, fatigue, drooling, tremor, and elevated prolactin. Long-term risks include metabolic changes and tardive dyskinesia. Monitoring includes weight, glucose, lipids, and prolactin levels.[1][3]
Alternatives if Risperdal Isn't Enough
Aripiprazole (Abilify) is another FDA-approved option for autistic irritability, with max doses of 15 mg/day (≥50 kg) or 10 mg/day (<50 kg). Behavioral therapies or other antipsychotics like olanzapine are off-label options, but risperdal has the strongest evidence base.[1][5]
Sources
[1] [Risperdal FDA Label (2015)]
[2] [StatPearls: Risperidone (2023)]
[3] [NEJM Risperidone Autism Trial (2002)]
[4] [Psychiatrist.com Review (2020)]
[5] [Abilify FDA Label (2014)]